US Broker Ratings

Ardent Health, Inc. (ARDT) Stock Analysis: Exploring a 26% Upside Potential

Ardent Health, Inc. (ARDT), a prominent player in the medical care facilities sector, is capturing investor attention with its robust growth trajectory and compelling upside potential...

Metsera, Inc. (MTSR) Stock Analysis: Exploring the Growth Potential in Biotechnology with a 6.42% Upside

Metsera, Inc. (NASDAQ: MTSR) is capturing the attention of investors as it navigates the promising, yet challenging, biotechnology sector. As a clinical-stage company focused on developing..

Addus HomeCare Corporation (ADUS) Stock Analysis: Exploring a 16.84% Potential Upside for Investors

In the dynamic landscape of healthcare services, Addus HomeCare Corporation (NASDAQ: ADUS) stands out with a robust market presence and a notable potential upside of 16.84%..

QuidelOrtho Corporation (QDEL) Stock Analysis: Navigating the 32.86% Potential Upside Amidst Healthcare Market Challenges

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare sector, specializes in diagnostic testing solutions that serve an array of medical needs globally. As it..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: Exploring a Potential 177% Upside in the Biotech Arena

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has consistently captured investor attention within the healthcare sector, particularly among specialty and generic drug manufacturers. With its headquarters in Durham,..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Unveiling a 157% Upside Potential in Biotechnology

Viking Therapeutics, Inc. (NASDAQ: VKTX) is capturing investor attention with its robust growth potential in the biotechnology sector. Specializing in developing innovative therapies for metabolic and..

Warby Parker Inc. (WRBY) Stock Analysis: Eyeing a 23.64% Upside Amid Robust Revenue Growth

Warby Parker Inc. (WRBY), a prominent player in the healthcare sector’s medical instruments and supplies industry, is making waves with a market capitalization of $2.62 billion...

HUTCHMED (China) Limited (HCM) Stock Analysis: A 51.71% Upside Potential and Strategic Partnerships Fuel Investor Interest

HUTCHMED (China) Limited (HCM), a dynamic player in the healthcare sector, stands out with a market cap of $2.6 billion and a compelling growth narrative. Operating..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: Exploring an 81% Potential Upside in the Biotech Sector

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a prominent player in the biotechnology industry, is currently capturing significant attention from investors, particularly those with an eye for potential..

Scholar Rock Holding Corporation (SRRK) Investor Outlook: A 52.61% Upside Opportunity in Biotech

Scholar Rock Holding Corporation (NASDAQ: SRRK) is capturing investor attention with a potential upside of 52.61%, a compelling figure for those interested in the biotechnology sector...

Haemonetics Corporation (HAE)

⚠️ No article content returned.

..

Concentra Group Holdings (CON): Healthcare Stock with a 36.74% Potential Upside

Concentra Group Holdings Parent, Inc. (CON) stands out in the healthcare sector as a noteworthy player within the medical care facilities industry. With a market capitalization..

Alvotech (ALVO) Stock Analysis: Exploring a 115% Potential Upside in the Biosimilars Market

Alvotech (NASDAQ: ALVO), a Luxembourg-based biopharmaceutical company, is carving a niche in the global healthcare sector with its focus on developing biosimilar medicines. This specialty and..

Immunovant, Inc. (IMVT) Stock Analysis: Unveiling a 78.88% Upside Potential in the Biotech Sector

Immunovant, Inc. (NASDAQ: IMVT), a promising clinical-stage biotechnology company, is capturing the attention of investors with its potential upside of 78.88%. As a key player in..

PTC Therapeutics, Inc. (PTCT) Investor Outlook: Navigating the Upside Potential with a Diverse Therapeutic Portfolio

PTC Therapeutics, Inc. (NASDAQ: PTCT), a pioneering force in biopharmaceuticals, has positioned itself as a key player in the healthcare sector by focusing on the treatment..

Arcellx, Inc. (ACLX) Stock Analysis: High Potential Upside with Strong Buy Ratings

Arcellx, Inc. (ACLX), a pioneering biotechnology company, is garnering significant attention in the healthcare sector for its innovative approach to immunotherapy. The company, headquartered in Redwood..

PROCEPT BioRobotics (PRCT) Stock Analysis: A 67.54% Potential Upside in the Medical Devices Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a promising player in the healthcare sector, is gaining investor attention due to its groundbreaking contributions to the medical devices industry...

Perrigo Company plc (PRGO) Stock Analysis: Exploring a 52.69% Potential Upside for Investors

Perrigo Company plc (PRGO), a cornerstone in the healthcare sector, offers a comprehensive suite of over-the-counter health and wellness products across various international markets. Headquartered in..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring a 51% Upside Potential

Inspire Medical Systems, Inc. (NYSE: INSP), a key player in the medical devices sector, has carved out a niche in the healthcare industry with its innovative..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Exploring Growth Potential with a 6.9% Upside

iRhythm Technologies, Inc. (IRTC), a pivotal player in the healthcare sector, is making waves in the medical devices industry with its innovative approach to cardiac monitoring...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds